Live
- Union Minister Pralhad Joshi dismisses Karnataka's claims of tax 'injustice'
- Secunderabad Cantonment MLA Ganesh extends wishes to CM Revanth Reddy and TPCC president
- BJP is a party of terrorists, alleges Mallikarjun Kharge
- Two Killed in Road Accident in Maddelagudem, Pinapaka
- Registration for PM Internship Scheme begins, over 80,000 opportunities available
- Eight Bangladeshi Nationals Detained for Illegal Stay in Udupi
- Telangana Government Inaugurates 2.5 Megawatt Power Plant at Ashwaraopet Palm Oil Factory
- CM Chandrababu keen on controlling prices of essentials
- Show the door to non-performers: PM Modi tells Union Secretaries
- Liverpool veteran defender Joel Matip confirms retirement from football
Gastrointestinal tumours associated with higher mortality
Researchers have determined that certain gastrointestinal tumours are more deadly than previously assumed.
Researchers have determined that certain gastrointestinal tumours are more deadly than previously assumed. Gastrointestinal stromal tumours (GISTs) may be malignant cancer or benign and are most commonly found in the stomach and small intestine and have significant variability in terms of size and malignant behaviour.
The finding, published online in the Journal of Gastrointestinal Surgery, showed that GISTs that are less than two cm cause 12.1 per cent mortality rate for five years. Also, up to 30 per cent of patients have GISTs less than two cm in size, or slightly more than half an inch, the researchers noted.
More than 79 per cent of patients have localised disease of GISTs, while for 11.4 per cent the disease can spread to other regions. Previously, researchers did not expect any disease to have spread.
"While GISTs are rare, we have found that certain groups of these tumours result in a much higher mortality than expected," said Jason Sicklick, assistant professor at University of California-San Diego in US. For the study, the team identified 378 patients with malignant GISTs of less than two cms between 2001 and 2011.
